Efficacy, safety and persistence of Ustekinumab versus Infliximab in bionaive patients with moderate to severe Crohn disease patients: a real world experience

by Nik Muhamad Affendi, Nik Arsyad, Xin Hui, Khoo, hilmi, ida normiha
Published 2022

Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease

by Nik Muhamad Affendi, Nik Arsyad, Xin Hui, Khoo, Chuah, Kee Huat, Hilmi, Ida
Published 2021

Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease

by Nik Muhamad Affendi, Nik Arsyad, Xin Hui, Khoo, Chuah, Kee Huat, Hilmi, ida normiha
Published 2022

Impact of early versus late use of biologic therapy on cumulative surgical rates in patients with IBD

by Fairul, Mohd, Nik Muhamad Affendi, Nik Arsyad, Shahrani, Shahreedhan, Xin Hui, Khoo, hilmi, ida normiha
Published 2022

Long term efficacy and persistence of biologics therapy in Crohn’s disease in multiracial Asian country

by Xin Hui, Khoo, Nik Muhamad Affendi, Nik Arsyad, Leow, Alex Hwong Ruey, Hilmi, Ida Normiha
Published 2023

Long term efficacy and persistence of Biologics Therapy in Crohn Disease in Multiracial Asian Country: A real world experience

by Nik Muhamad Affendi, Nik Arsyad, Xin Hui, Khoo, leow, alex hwong ruey, hilmi, ida normiha
Published 2023

High accuracy of a simplified, practical algorithm in a differentiating Crohn’s disease from Intestinal Tuberculosis

by hilmi, ida normiha, Nik Muhamad Affendi, Nik Arsyad, Shahrani, Shahreedhan, Mohamed Talha, Abdul Malik, Leow, alex hwong-ruey, Xin Hui, Khoo
Published 2023